CY1113492T1 - MODIFIED PROTEIN FIELDS - Google Patents
MODIFIED PROTEIN FIELDSInfo
- Publication number
- CY1113492T1 CY1113492T1 CY20121101249T CY121101249T CY1113492T1 CY 1113492 T1 CY1113492 T1 CY 1113492T1 CY 20121101249 T CY20121101249 T CY 20121101249T CY 121101249 T CY121101249 T CY 121101249T CY 1113492 T1 CY1113492 T1 CY 1113492T1
- Authority
- CY
- Cyprus
- Prior art keywords
- modified
- domains
- protein
- modified protein
- fields
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Η παρούσα εφεύρεση παρέχει μια τροποποιημένη πρωτεΐνη πολλαπλών πεδίων που περιλαμβάνει τουλάχιστον δύο μη πανομοιότυπα τροποποιημένα πεδία, κάθε ένα από τα οποία περιέχει μια διεπιφάνεια αλληλεπίδρασης πρωτεΐνης-πρωτεΐνης που περιέχει τμήματα αλληλουχιών αμινοξέων που προέρχονται από δύο ή περισσότερα υπάρχοντα ομόλογα μητρικά πεδία, παρέχοντας επομένως στα τροποποιημένα πεδία ειδικότητες συγκρότησης διακριτές από τις ειδικότητες συγκρότησης των μητρικών πεδίων. Συγκεκριμένα, τα τροποποιημένα πεδία σχηματίζουν κατά προτίμηση ετεροδιμερή το ένα με το άλλο από το να σχηματίζουν ομοδιμερή. Επίσης περιλαμβάνονται μέθοδοι σχεδιασμού και χρήσης των τροποποιημένων πρωτεϊνών.The present invention provides a modified multi-domain protein comprising at least two non-identical modified domains, each of which contains a protein-protein interaction interface comprising fragments of amino acid sequences derived from two or more existing homologous parental domains, assembly field specialties distinct from the parent field assembly properties. In particular, the modified domains preferably form heterodimers with each other than form homodimers. Also included are methods for designing and using modified proteins.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78547406A | 2006-03-24 | 2006-03-24 | |
EP20070723539 EP1999154B1 (en) | 2006-03-24 | 2007-03-23 | Engineered heterodimeric protein domains |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1113492T1 true CY1113492T1 (en) | 2016-06-22 |
Family
ID=58448862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20121101249T CY1113492T1 (en) | 2006-03-24 | 2012-12-21 | MODIFIED PROTEIN FIELDS |
Country Status (1)
Country | Link |
---|---|
CY (1) | CY1113492T1 (en) |
-
2012
- 2012-12-21 CY CY20121101249T patent/CY1113492T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122195T1 (en) | SERPIN FUSION POLYPEPTIDES AND METHODS OF USING THEM | |
CY1120822T1 (en) | SPECIAL SPECIFIC COMMITMENT TERRITORY | |
WO2007110205A3 (en) | Engineered heterodimeric protein domains | |
CY1121632T1 (en) | RV2386C TUBERCULOSIS PROTEIN, ITS COMPOSITIONS AND USES | |
BR112018012784A2 (en) | nucleic acids encoding proline and alanine residue-rich repetitive amino acid sequences that have low repeat nucleotide sequences | |
CY1121962T1 (en) | T CELL RECEPTORS | |
CY1117975T1 (en) | STABILIZED FIELD COMPOSITIONS OF FIELDS, METHODS AND USES | |
CY1118008T1 (en) | PARTICULAR BINDING PROTEINS AND THEIR USES | |
CY1119647T1 (en) | ALUMINUM ACCESSORIES AND ACCESSORIES FOR ACCESSORIES | |
CY1114851T1 (en) | IL-1BIT BINDING antibodies and their fragments | |
CY1118979T1 (en) | ANTIBODIES DIRECTED AGAINST HER-3 AND USE OF THESE | |
CY1117351T1 (en) | JNK-CELL SIGNIFICANT Peptide Suspensions - Signaling Pathway | |
CO7170123A2 (en) | Complex of factor viii with xten and von willebrand factor protein and its uses | |
CY1121049T1 (en) | INNOVATIVE SIGNAL SEQUENCES FOR IMPROVING PROTEIN EXPRESSIONS AND SECRETATION OF RECOVERY ENZYMES AND OTHER PROTEINS | |
WO2013075066A3 (en) | Variant serum albumin with improved half -life and other properties | |
CY1114584T1 (en) | RECOVERABLE VACCINES AND USE OF THESE | |
BRPI0515649B8 (en) | Process for preparing highly concentrated monoclonal antibody compositions | |
BR112014001573B8 (en) | MULTIVALENT ANTIGEN FV MOLECULE | |
CO6280541A2 (en) | MONOCLONAL ANTIBODIES OR FRAGMENTS OF THE SAME THAT JOIN THE HXAN RECEIVER OX40 | |
WO2007133835A3 (en) | Ras mutation and compositions and methods related thereto | |
BR112012004697B8 (en) | method for purifying a polypeptide comprising a ch2/ch3 region | |
EA201100071A1 (en) | NEW COMPOSITIONS AND METHODS | |
UY30925A1 (en) | IMMUNOGLOBULIN FUSION PROTEINS AND ELABORATION METHODS | |
ATE447414T1 (en) | USE OF ACTIVATED POLYMERS TO SEPARATE PROTEIN AND POLYPEPTIDE MULTIMERS | |
CY1123997T1 (en) | NEW HUMAN SERUM ALBUMIN MUTATION |